Wealthspire Advisors (New York)’s Guardant Health GH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$546K	Sell	3,636 -19	-0.5%	-$2.07K	﹤0.01%	772
2026 Q1	$338K	Sell	3,655 -231	-6%	-$23.2K	﹤0.01%	689
2025 Q4	$397K	Buy	3,886 +235	+6%	+$21K	﹤0.01%	694
2025 Q3	$228K	Buy	+3,651	New	+$199K	﹤0.01%	753

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wealthspire Advisors (New York)'s GH Position: Q2 2026 in Review

Wealthspire Advisors (New York) reduced its Guardant Health (GH) stake by 0.52% in Q2 2026, selling an estimated $2.07K and leaving 3,636 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Wealthspire Advisors (New York) first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Wealthspire Advisors (New York) held 3,636 shares of Guardant Health worth $546K as of Q2 2026.
Wealthspire Advisors (New York) sold 19 Guardant Health shares in Q2 2026, an estimated $2.07K.
Guardant Health made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #772 holding.
Wealthspire Advisors (New York) first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.